1800 202 8726
Biopsy complications

Needle Track Seeding: — The Real Evidence

Many patients fear that a biopsy needle can spread cancer cells along its path. This does happen — but it is documented as extremely rare, and in most patients it does not change what happens to you. The risk of leaving a cancer undiagnosed is far greater.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • It is documented — Needle track seeding appears in medical literature, most often in specific cancer types such as mesothelioma.
  • But it is extremely rare — NCCN and ESMO continue to recommend biopsy because the diagnostic benefit substantially outweighs the risk.
  • Rarely changes outcome — Even when seeding occurs, it infrequently causes active growing disease or alters treatment decisions.
  • Technique reduces risk further — Image-guided, coaxial-needle biopsy limits the number of separate passes through tissue.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Speak to our team now

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Needle track seeding — cancer cells depositing along the biopsy needle path — is a documented complication but is vanishingly rare across most tumour types. NCCN and ESMO continue to recommend biopsy because the diagnostic benefit substantially outweighs the risk. In the great majority of patients, seeding does not cause active disease or alter treatment outcome.

If a symptom below applies to you, do not wait for a callback. Call 1800-202-8726 or go to your nearest emergency department.

If you are worried right now, call

Our helpline is answered by clinical staff. If a symptom is on the list above, do not wait for a callback — call, or go to your nearest emergency department.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Not sure whether this counts as an emergency?

Call the helpline. It is always better to check than to wait.

Book Free Consultation Call 1800 202 8726

Which biopsies carry higher documented seeding concern?

FeatureLower documented concernHigher documented concern
Cancer typeMost solid tumours — lung, breast, prostate, kidneyMesothelioma and hepatocellular carcinoma — higher rates noted in some published series
Needle techniqueImage-guided biopsy with a coaxial sheath, limiting tissue passesMultiple separate needle passes without a coaxial sheath
Clinical impactSeeding cells detected but not causing any apparent diseaseRare track nodule that appears and requires additional treatment
Typically startsSeeding event occurs at the time of the biopsy procedureIf a track nodule appears, it is typically found months to years afterwards

What should I discuss with my team and watch for after biopsy?

  • Tell your oncologist you have read about seeding. Ask what technique and needle type will be used for your specific biopsy.
  • Do not postpone a recommended biopsy on seeding grounds without first discussing the risk and benefit with your team.
  • Note the exact location of the needle entry point after the procedure so you can monitor that area.
  • Report any new lump near the biopsy site at your next appointment — or sooner if it appears and grows quickly.

Explore 100 more Preparing For, Having and Recovering From a Biopsy topics

HUB — Preparing for a Biopsy and What Happens on the Day

All Preparing For, Having and Recovering From a Biopsy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Does needle track seeding actually happen?

Yes, it is documented in medical literature, but it is recognised as rare. The cases that appear in published reports are concentrated in specific cancer types — mesothelioma and hepatocellular carcinoma show higher rates in some series than most other solid tumours. For the great majority of biopsies, NCCN, ESMO and ASCO continue to recommend the procedure because the benefit of a tissue diagnosis outweighs the seeding risk. Documented does not mean common.

Does seeding from a biopsy change survival or treatment outcome?

In most patients it does not. Even in the rare cases where seeding is detected, the deposited cells often do not go on to cause active, growing disease — and when they do, the track nodule is typically treatable. The published literature describes clinically significant seeding as uncommon even among patients where some degree of cellular tracking may have occurred. The cancer that was not biopsied, and therefore not diagnosed in time, is a far greater threat to outcome.

Is there a safer biopsy technique that reduces seeding risk?

Yes. Image guidance — ultrasound or CT — allows the radiologist to reach the target accurately with fewer passes. A coaxial needle system, where an outer sheath is placed first and the sampling needle passes through it, means the needle does not cross tissue planes repeatedly. Ask your team whether these techniques apply to your biopsy. For most biopsies done in a well-equipped centre, some combination of these approaches is already standard practice.

Should I refuse a biopsy because of seeding risk?

No. A biopsy is usually the only way to confirm the diagnosis, identify the cancer type, and select the right treatment. Refusing leaves the cancer uncharacterised, which means treatment decisions are made on guesswork and staging may be delayed. The documented risk of clinically significant seeding is substantially lower than the risk of an undiagnosed or mistreated cancer. If you have concerns about technique, discuss them with your oncologist before the procedure — not instead of it.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation